dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Ductus Arteriosus, Patent in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlos, RQ; Davonzo, C; Dimaguila, MA; Gal, P; McPherson, C; Ransom, JL; Smith, M; Wimmer, JE | 1 |
| Buck, R; Garland, J; Weinberg, M | 1 |
| Malathi, I; Ng, KC | 1 |
| Anday, E; Easa, D; Gong, A; LeBlanc, M; Long, W; Pauly, T; Pramanik, A; Sell, M; Stevenson, D; Walther, F | 1 |
1 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Survival Analysis | 1992 |
3 other study(ies) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Biological Products; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Ductus Arteriosus, Patent; Echocardiography; Echocardiography, Doppler, Color; Fatty Alcohols; Guideline Adherence; Humans; Indomethacin; Infant, Newborn; Intensive Care Units, Neonatal; Kidney; Metabolic Clearance Rate; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 2010 |
Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Topics: Cohort Studies; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemorrhage; Humans; Infant, Newborn; Lung Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 1994 |
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemodynamics; Humans; Hyaline Membrane Disease; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Pulmonary Ventilation; Remission Induction; Respiration, Artificial; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ventilation-Perfusion Ratio | 1995 |